Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 July 1999

Effect of treatment with methylprednisolone upon concentration of soluble form of IL-2R alpha and soluble forms of adhesive molecules : ICAM-1 and VCAM-1 in serum of patients with multiple sclerosis

Małgorzata Bilińska, Irena Frydecka, Ryszard Podemski

Med Sci Monit 1999; 5(4): CR692-696 :: ID: 503491

Abstract

The bout of multiple sclerosis implies activation of autoreactive mononuclear cells of peripheral blood and increased expression of adhesive cells on cerebral vessel endothelium. This results in the migration of cells and consequently, in the formation of perivascular infiltrations consisting of lymphocytes and macrophages, as well as the destruction of myelin in the brain and spinal cord. Steroid-therapy reduces clinical symptoms of MS bout, while nuclear magnetic resonance reveals the decrease of demyelinization foci after treatment. The aim of the present work was to evaluate the effect of methylprednisolone therapy upon the activation of immune system and clinical status estimated on EDSS scale. In our study, concentrations of sIL-2R alpha, sICAM-1 and sVCAM-1 were investigated in blood serum with the use of ELISA immunoenzyme assay. The study was performed in the group of 15 patients with the first bout of multiple sclerosis, who received intravenous infusion of methylprednisolone (1g) daily for 5 consecutive days. Neurological examinations as well as the determination of serum levels of cellular differentiation antigens listed above were performed before the start of therapy and 4 weeks after its completion. Control group was formed of 20 healthy persons. In patients with the first bout of the disease, mean serum concentrations of sIL-2R, sICAM-1 and sVCAM-1 were significantly higher when compared with the results obtained in control group. 4 weeks after therapy with methylprednisolone, a considerable improvement of neurological status was observed in patients from the study group. At that time, return to normal serum levels of mean sVCAM-1 concentration and a considerable decrease of mean sICAM-1 concentration were observed, while mean level of sIL-2R alpha did not change in a significant way. The improvement on EDDS scale after treatment correlated with the decrease of sICAM-1 in blood serum. The results of our study suggest that a beneficial clinical effect of steroid therapy in patients with multiple sclerosis may partly result from its inhibiting influence on the expression of adhesive cells, which consequently may lead to reduced migration of activated cells of immune system to central nervous system.

Keywords: Immune System, steroid therapy, Multiple Sclerosis

0 Comments

Editorial

01 January 2023 : Editorial  

Editorial: Current Status of Two Adjuvanted Malaria Vaccines and the World Health Organization (WHO) Strategy to Eradicate Malaria by 2030

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.939357

Med Sci Monit 2023; 29:e939357

SARS-CoV-2/COVID-19

26 January 2023 : Editorial  

Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread

Med Sci Monit In Press; DOI: 10.12659/MSM.939580  

19 January 2023 : Clinical Research  

Evaluation of Health-Related Quality of Life and Mental Health in 729 Medical Students in Indonesia During ...

Med Sci Monit In Press; DOI: 10.12659/MSM.938892  

27 December 2022 : Clinical Research  

Effect of Physiotherapy to Correct Rounded Shoulder Posture in 30 Patients During the COVID-19 Pandemic in ...

Med Sci Monit 2022; 28:e938926

In Press

27 Jan 2023 : Database Analysis  

Association Between Neutrophil-Lymphocyte Ratio and All-Cause Mortality in Critically Ill Patients with Chr...

Med Sci Monit In Press; DOI: 10.12659/MSM.938554  

27 Jan 2023 : Clinical Research  

Proposal for a Simple Equation for Limb Muscle Weight Calculation

Med Sci Monit In Press; DOI: 10.12659/MSM.938606  

26 Jan 2023 : Editorial  

Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread

Med Sci Monit In Press; DOI: 10.12659/MSM.939580  

20 Jan 2023 : Clinical Research  

A Study of 42 Partially Edentulous Patients with Single-Crown Restorations and Implants to Compare Bone Los...

Med Sci Monit In Press; DOI: 10.12659/MSM.939225  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750